We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+14.32%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$889M
AUM Growth
-$164M
Cap. Flow
-$239M
Cap. Flow %
-26.87%
Top 10 Hldgs %
50.84%
Holding
103
New
31
Increased
13
Reduced
14
Closed
37

Top Buys

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$27.8M
2
MDT icon
Medtronic
MDT
+$25.2M
3
COO icon
Cooper Companies
COO
+$10.7M
4
DXCM icon
DexCom
DXCM
+$9.85M
5
FMS icon
Fresenius Medical Care
FMS
+$8.86M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$43.3M
2
HUM icon
Humana
HUM
+$28M
3
UHS icon
Universal Health Services
UHS
+$24M
4
BDX icon
Becton Dickinson
BDX
+$17.5M
5
CI icon
Cigna
CI
+$16.5M

Sector Composition

Rank Sector Weight
1 Healthcare 95.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSM icon
1
Insmed
INSM
$21.4B
$106M 11.91%
1,450,000
-100,000
-6% -$7.38M
THC icon
2
Tenet Healthcare
THC
$20.4B
$88.1M 9.91%
530,000
+30,000
+6% +$4.54M
BSX icon
3
Boston Scientific
BSX
$71.1B
$46.1M 5.19%
550,000
-100,000
-15% -$7.88M
CYTK icon
4
Cytokinetics
CYTK
$10.7B
$39.6M 4.46%
750,000
-250,000
-25% -$13.9M
LBPH
5
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$35M 3.94%
1,050,000
-50,000
-5% -$1.72M
INSP icon
6
Inspire Medical Systems
INSP
$1.85B
$33.8M 3.8%
+160,000
New +$27.8M
MDT icon
7
Medtronic
MDT
$110B
$27M 3.04%
+300,000
New +$25.2M
BPMC
8
DELISTED
Blueprint Medicines
BPMC
$26.8M 3.02%
290,000
-50,000
-15% -$4.97M
EHC icon
9
Encompass Health
EHC
$11B
$26.6M 2.99%
275,000
-25,000
-8% -$2.25M
NVS icon
10
Novartis
NVS
$291B
$23M 2.59%
200,000
-100,000
-33% -$11.3M
ACLX
11
DELISTED
Arcellx
ACLX
$23M 2.58%
275,000
– –
MRK icon
12
Merck
MRK
$316B
$22.7M 2.56%
200,000
-35,000
-15% -$4.16M
VERA icon
13
Vera Therapeutics
VERA
$2.15B
$22.1M 2.49%
500,000
– –
DGX icon
14
Quest Diagnostics
DGX
$25.8B
$18.6M 2.1%
120,000
+20,000
+20% +$2.99M
NARI
15
DELISTED
Inari Medical, Inc. Common Stock
NARI
$16.5M 1.86%
400,000
– –
RVMD icon
16
Revolution Medicines
RVMD
$41.1B
$15.9M 1.79%
350,000
+25,000
+8% +$1.09M
VKTX icon
17
CALL
Viking Therapeutics
VKTX
$3.84B
$15.8M 1.78%
250,000
– –
CRNX icon
18
Crinetics Pharmaceuticals
CRNX
$8.9B
$15.3M 1.72%
300,000
-100,000
-25% -$5.16M
RGNX icon
19
Regenxbio
RGNX
$659M
$13.4M 1.5%
1,275,000
+325,000
+34% +$3.96M
EWTX icon
20
CALL
Edgewise Therapeutics
EWTX
$4.81B
$13.3M 1.5%
+500,000
New +$9.95M
TARS icon
21
Tarsus Pharmaceuticals
TARS
$2.67B
$12.3M 1.39%
375,000
-215,000
-36% -$6.04M
COO icon
22
Cooper Companies
COO
$14.6B
$12.1M 1.37%
+110,000
New +$10.7M
KROS icon
23
Keros Therapeutics
KROS
$203M
$11.6M 1.31%
200,000
+115,000
+135% +$5.68M
MLTX icon
24
MoonLake Immunotherapeutics
MLTX
$1.53B
$11.1M 1.25%
220,000
– –
CLDX icon
25
CALL
Celldex Therapeutics
CLDX
$3.07B
$10.2M 1.15%
+300,000
New +$11.4M
1
2 3 4 5

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
NSCM
New South Capital Management Memphis, Tennessee $2.09B AUM 33.67% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

Integral Health Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Integral Health Asset Management held 103 positions worth $889M, down 16% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Integral Health Asset Management withdrew a net $239M in Q3 2024, closing 37 positions and reducing 14 holdings. Its most notable exit was Elevance Health, an estimated $43.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier.

Against the trend, Integral Health Asset Management opened a new position in Inspire Medical Systems worth $33.8M.

  • Integral Health Asset Management's largest Q3 2024 buy was Inspire Medical Systems: 160,000 shares worth $33.8M.
  • Integral Health Asset Management added most to Keros Therapeutics in Q3 2024, an estimated $5.68M increase.
  • Integral Health Asset Management's biggest Q3 2024 reduction was Cytokinetics, cutting an estimated $13.9M.
  • Integral Health Asset Management fully exited Elevance Health in Q3 2024, selling an estimated $43.3M.
  • Integral Health Asset Management's ten largest holdings make up 51% of its $889M portfolio in Q3 2024.
  • Integral Health Asset Management opened 31 new positions and closed 37 in Q3 2024.
  • Integral Health Asset Management's portfolio value fell 16% quarter-over-quarter to $889M.

Based on Integral Health Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.